| 127 | 0 | 113 |
| 下载次数 | 被引频次 | 阅读次数 |
<正>肺癌是世界范围内发病率及死亡率最高的肿瘤之一,其中非小细胞肺癌(non-small cell lung cancer,NSCLC)约占80%[1]。相对于小细胞肺癌,NSCLC的治疗手段可选择性相对较多(手术、化疗、放疗、靶向、免疫),使得NSCLC患者的总生存期(overall survival,OS)及无疾病进展生存期(progression-free survival,PFS)明显延长。但是,仍有一部分患者出现远处转移从而影响预后。现报道1例肺腺癌广泛腹膜转移(peritoneal carcinomatosis,PC)病例。
Abstract:[1]Niu F Y,Zhou Q,Yang J J,et al.Distribution and prognosis of uncommon metastases from non-small cell lung cancer[J].BMC Cancer,2016,16:149.
[2]Hanane K,Salma B,Khadija B,et al.Peritoneal carcinomatosis,an unusual and only site of metastasis from lung adenocarcinoma[J].Pan Afr Med J,2016,23:60.
[3]Satoh H,Ishikawa H,Yamashita Y,et al.Peritoneal carcinomatosis in lung cancer patients[J].Oncol Rep,2001,8(6):1305-1307.DOI:10.3969/j.issn.2096-6113.2021.03.008
[4]Tejas P,Dara L,Aisnerb S A,et al.Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stageⅣnon-small cell lung cancer independent of oncogene status[J].Lung Cancer,2016,96:27-32.
[5]Cao B S,Liu Y,Yin W C,et al.A single center,retrospective analysis of prognosis in non-small cell lung cancer patients with peritoneal carcinomatosis[J].Chin J Lung Cancer,2019,22(3):143-150.
[6]Su H T,Tsai C M,Perng R P.Peritoneal carcinomatosis in lung cancer[J].Respirology,2008,13(3):465-467.
[7]Doebele R C,Lu X,Sumey C,et al.Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer[J].Cancer,2012,118(18):4502-4511.
[8]Takagi Y,Sato T,Morio Y,et al.A pleuro-peritoneal communication through the diaphragm affected with lymphangioleiomyomatosis[J].Intern Med,2010,49(5):439-445.
[9]Kamaleshwaran K K,Joseph J,Kalarikal R K,et al.Image findings of rare case of peritoneal carcinomatosis from non small cell lung cancer and response to Erlotinib in F-18FDG Positron Emission Tomography/Computed Tomography[J].Indian J Nucl Med,2017,32(2):140-142.
[10]Hsu J F,Lee Y L,Chang H L,et al.Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung[J].Asia Pac JClin Oncol,2019,15(5):e126-131.
[11]Verheul H M,Hoekman K,Jorna A S,et al.Targeting vascular endothelial growth factor blockade:ascites and pleural effusion formation[J].Oncologist,2000,1:45-50.
[12]Kobayashi H,Wakuda K,Takahashi T.Effectiveness of afatinib in lung cancer with paralytic ileus due to peritoneal carcinomatosis[J].Respirol Case Rep,2016,4(6):e00197.
[13]Taro S,Eri I,Shinnosuke I,et al.A case of pulmonary adenocarcinoma showing rapid progression of peritoneal dissemination after immune checkpoint inhibitor therapy[J].BMC Cancer,2018,18(1):620.
[14]Sibio S,Sica G S,Di Carlo S,et al.Surgical treatment of intraperitoneal metastases from lung cancer:two case reports and a review of the literature[J].J Med Case Rep,2019,13(1):262.
基本信息:
中图分类号:R734.2
引用信息:
[1]陈卓,许新华.肺腺癌腹膜转移1例并文献复习[J].巴楚医学,2021,4(03):19-21.
基金信息:
湖北省卫生厅科研项目(No:JX4B52)
2021-09-30
2021-09-30